IOVA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Iovance Biotherapeutics Inc

Watchlist Manager

Watchlist

Price: 3.93 USD -2.72% Market Closed

Market Cap: $1.8B

	Iovance Biotherapeutics Inc NASDAQ:IOVA	US
C	Camurus AB F:7CA	SE
	Essity AB (publ) F:ESW	SE
E	Eiffage SA F:EF3	FR
	Synectics PLC LSE:SNX	UK
F	First Majestic Silver Corp DUS:FMV	CA
	China Shenhua Energy Co Ltd SSE:601088	CN
T	TFI International Inc XBER:9TF	CA
A	AMP Ltd NZX:AMP	AU
	Standard Chartered PLC LSE:STAN	UK
A	Anglo American PLC SWB:NGLB	UK
	Covivio SA PAR:COV	FR
	LATAM Airlines Group SA SGO:LTM	CL
M	Majestic Gold Corp F:MJT	CA
C	Cloudflare Inc XMUN:8CF	US

Profitability Summary

Iovance Biotherapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Healthy Gross Margin

37%

Negative 3Y Average Gross Margin

-256%

Gross Margin is Increasing

-754% > 37%

Negative Operating Margin

-127%

Negative 3Y Average Operating Margin

-25 626%

Operating Margin is Increasing

-178 496% > -127%

Negative Net Margin

-124%

Negative 3Y Average Net Margin

-24 935%

Net Margin is Increasing

-174 517% > -124%

Negative Free Cash Flow Margin

-107%

Negative 3Y Average Free Cash Flow Margin

-21 417%

Free Cash Flow Margin is Increasing

-147 783% > -107%

Negative ROE

-48%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-96%

ROIC is Increasing

-133% > -63%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.